Oncotelic Therapeutics (OTLC) Net Equity Issued and Repurchased (2010 - 2026)
Oncotelic Therapeutics' Net Equity Issued and Repurchased came in at $6,630 for Q2 2026.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Oncotelic Therapeutics reported Net Equity Issued and Repurchased of -$1,325; for FY2022, it came in at $158,820, down 89.7% from FY2021.
- Net Equity Issued and Repurchased carries a four-year compound annual growth rate of -9.8% (FY2018 to FY2022).
- Going back by year, Net Equity Issued and Repurchased was $1.55 million in FY2021 (-47.3%), $2.93 million in FY2020, $83,000 in FY2019 (-65.4%) and $240,000 in FY2018.
- The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | - |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 6,630.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,630.00 |
| Sep 30, 2022 | 85,193.00 |
| Dec 31, 2021 | 233,551.00 |
| Sep 30, 2021 | 48,486.00 |
| Jun 30, 2021 | 70,108.00 |
| Mar 31, 2021 | 1.61 Mn |
| Dec 31, 2020 | 624,515.00 |
| Dec 31, 2019 | -120.00 |
| Jun 30, 2019 | 120.00 |
| Mar 31, 2019 | 83,000.00 |
| Dec 31, 2018 | 40,000.00 |
| Dec 31, 2015 | -1,000.00 |
| Jun 30, 2015 | -12,000.00 |
| Mar 31, 2015 | 9.21 Mn |
| Dec 31, 2014 | 1,000.00 |
| Jun 30, 2014 | 14.84 Mn |
| Mar 31, 2014 | 20.35 Mn |
| Dec 31, 2013 | 393,000.00 |
| Sep 30, 2013 | 2.57 Mn |
| Jun 30, 2013 | 426,000.00 |
API Access
Oncotelic Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();